Dermata Therapeutics, Inc. (DRMA) Operating cash flow 2021–2026
Dermata Therapeutics, Inc. (DRMA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.8MFY2026 · since FY2021: -$4.0M → -$7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$7.8M | +30.1% |
| FY2025 | -$11.2M | -74.2% |
| FY2024 | -$6.4M | +27.5% |
| FY2023 | -$8.8M | -55.2% |
| FY2022 | -$5.7M | -41.3% |
| FY2021 | -$4.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice